[1]
Martins, J.C. et al. 2026. Stage I human epidermal growth factor receptor-type 2-positive breast cancer: is systemic therapy required?. Mastology. 35, suppl.1 (Feb. 2026). DOI:https://doi.org/10.29289/259453942025V35S1026.